271 related articles for article (PubMed ID: 23540162)
1. When to repeat thyroid fine needle aspiration cytology?
Moslavac S; Matesa-Anić D; Matesa N; Kusić Z
Acta Clin Croat; 2012 Dec; 51(4):549-54. PubMed ID: 23540162
[TBL] [Abstract][Full Text] [Related]
2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
[TBL] [Abstract][Full Text] [Related]
6. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
[TBL] [Abstract][Full Text] [Related]
8. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
[No Abstract] [Full Text] [Related]
9. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
10. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation.
Deandrea M; Ragazzoni F; Motta M; Torchio B; Mormile A; Garino F; Magliona G; Gamarra E; Ramunni MJ; Garberoglio R; Limone PP
Thyroid; 2010 Oct; 20(10):1077-83. PubMed ID: 20883171
[TBL] [Abstract][Full Text] [Related]
12. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
13. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
14. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
Lew JI; Snyder RA; Sanchez YM; Solorzano CC
J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
[TBL] [Abstract][Full Text] [Related]
15. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
[TBL] [Abstract][Full Text] [Related]
16. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe.
Cochand-Priollet B; Schmitt FC; Tötsch M; Vielh P;
Acta Cytol; 2011; 55(6):507-11. PubMed ID: 22156458
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy.
Raparia K; Min SK; Mody DR; Anton R; Amrikachi M
Arch Pathol Lab Med; 2009 May; 133(5):787-90. PubMed ID: 19415954
[TBL] [Abstract][Full Text] [Related]
18. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology.
Dabelić N; Matesa N; Matesa-Anić D; Kusić Z
Coll Antropol; 2010 Jun; 34(2):349-54. PubMed ID: 20698101
[TBL] [Abstract][Full Text] [Related]
19. Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk.
Jo VY; Vanderlaan PA; Marqusee E; Krane JF
Acta Cytol; 2011; 55(6):539-43. PubMed ID: 22156463
[TBL] [Abstract][Full Text] [Related]
20. ThinPrep for cytologic evaluation of follicular thyroid lesions: correlation with histologic findings.
Tulecke MA; Wang HH
Diagn Cytopathol; 2004 Jan; 30(1):7-13. PubMed ID: 14696138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]